Vemurafenib (PLX4032, Zelboraf®), a BRAF Inhibitor, Modulates ABCB1-, ABCG2-, and ABCC10-Mediated Multidrug Resistance. J. Can. Res. Updates. 2013;2(4): 306-317. doi:10.6000/1929-2279.2013.02.04.9